Journal
CELLULAR IMMUNOLOGY
Volume 237, Issue 1, Pages 68-75Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2005.10.002
Keywords
cysteine protease; asthma; airway inflammation; CD4(+) T cells; IL-13; immunomodulation
Categories
Funding
- NCCIH NIH HHS [F32 AT001569-01A1, FG32-AT001569, F32 AT001569-02, F32 AT001569] Funding Source: Medline
- NIAID NIH HHS [R01 AI043573, AI R01 HL-43573, R01 AI043573-06, R01 AI043573-07] Funding Source: Medline
Ask authors/readers for more resources
Objective: Bromelain, a clinically used pineapple extract and natural product, has reported anti-inflammatory and immunomodulatory activities. The purpose of this study was to determine the effect of bromelain treatment in an ovalbumin (OVA)-induced murine model of allergic airway disease (AAD). Methods: To establish AAD, mice were sensitized with intraperitoneal (i.p.) OVA/alum and challenged with daily OVA aerosols. Mice were treated i.p. with either saline, 2 or 6 mg/kg bromelain, twice daily for four consecutive days. Bronchoalveolar lavage leukocytes and cytokines, lung histology, airway hyperresponsiveness, and lymphocyte populations via flow cytometry were compared between groups. Results: Bromelain treatment of AAD mice resulted in reduced total BAL leukocytes, eosinophils, CD4(+) and CD8(+) T lymphocytes, CD4(+)/CD8(+) T cell ratio, and IL-13. Conclusion: Bromelain attenuated development of AAD while altering CD4(+) to CD8(+) T lymphocyte populations. The reduction in AAD outcomes suggests that bromelain may have similar effects in the treatment of human asthma and hypersensitivity disorders. (c) 2005 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available